Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5705_Библиотеки_им_академика_М_И_Перельмана.pdf
288
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
Regenerative Medicine
3–32.
Int. J. Emerg. Technol. Adv. Eng. 2012, 2 (4), 91–101.
tissue engineering. Chemical Society Reviews 2009, 38 (4), 1139–1151.
Polym. Rev. 2008, 48 (1), 11–63.
Polymers 2021, 13 (7), 1105.
Int. J. Biol.
Macromol. 2013, 62, 465–471.
et al.
Biomaterials 2014, 35 (28), 8154–8163.
Smart Mater. Manufact. 2023,
1, 100011–100027.
Annal. Biomed.
Eng. 2015, 43 (3), 657–680.
J. R. Soc. Interface
2009, 6
Adv. Sci. 2019, 6, 1801664–1801711.
Adv.
Healthc. Mater. 2018, 7, 1701503–1701513.
J. Funct. Biomater. 2018, 9 (1), 17.
Adv. Exp. Med. Biol. 2022, 1–28.
Materials. Surf. Sci. 2002, 500 (1–3), 61–83.
et al.
J. Pediatr. Surg. 1988, 23 (1), 3–9.
Current Status and Challenges 2022, 193–236.
J. Biomed. Mater. Res. Part B Appl. Mater. 2022, 110, 1206–1214.
Handbook of Nanostructured Biomaterials and Their Applications in Nanobiotechnology
2005, 1, 1–23.
Nanotechnology-based Polymeric Scaffolds in Tissue Engineering
289
et al.
Skin Fibroblast Cell Culture. J. Biomed. Mater. Res. 2002, 62 (3), 438–446.
et al.
Mater. Lett. 2013, 93, 133–136.
Engineering. Adv. Healthc. Mater. 2015, 4 (9), 1268–1285.
et al.
Emerg. Mater.
2019, 2 (2), 141–151.
Advances in Pharmaceutical T echnology for Drug Delivery Systems (PTDDS), Volume 2: Recent Progress
in Biomedical Applications. Sougata Jana (Ed.)
© 2025 Apple Academic Press, Inc. Co-published with CRC Press (Taylor & Francis)
Bioceramics System for Biomedical
Application
V. LALZAWMLIANA
1
, PRASENJIT MUKHERJEE
2
, SUBHASIS ROY
2
,
SHUBHAMITRA CHAUDHURI
2
, and SAMIT KUMAR NANDI
3
1
2
3
CHAPTER 10
ABSTRACT
-
-
approaches such as orthopedic surgery, drug delivery systems, dental
discuss recent advancements in bioceramics systems and their application
in biomedical sciences.
292
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
10.1 INTRODUCTION
-
(titanium or tantalum), polymers (polylactides), hydrogel-based mate-
rials, bioceramics, biocomposite structures, etc. (Bohner et al., 2012).
various biomedical applications such as hip and knee replacement, and
(Saini et al., 2015).
Bioceramics System for Biomedical Application
293
-
-
-
materials are mostly bioactive and bioresorbable ceramics, such as calcium
should degrade at the same rate as the tissue regeneration and excrete
294
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
10.2 IDEAL PROPERTIES OF BIOCERAMICS
usually 3D structures to provide mechanical support and also promote the
-
causing any adverse reaction to the body . In addition to its acceptance by the
10.2.1 MECHANICAL PROPERTY
-
optimum in vivo
completely regenerated (Hollinger and Chaudhari, 1992). Additionally, the
ceramic material must possess other properties such as optimum elasticity,
-
Bioceramics System for Biomedical Application
295
-
2015).
10.2.2 POROSITY, PORE SIZE, AND SHAPE
-
296
Advances in Pharmaceutical Technology for Drug Delivery Systems (PTDDS), Volume 2
-
bone healing. A larger interconnected pore structure can be attained by rapid
-
(Leong et al., 2003).
10.2.3 BIOCOMPATIBILITY AND BIODEGRADABILITY
-
be nontoxic, nonteratogenic, noncarcinogenic, nonallergic, nonhemolytic,
-
Bioceramics System for Biomedical Application
297
bioresorbable properties (Bohner, 2000).
10.2.4 OSTEOCONDUCTIVITY AND OSSEOINTEGRITY
-
and biodegradability (Li et al., 2021). Besides, osteointegration means the
-
-